Xtant Medical Holdings (XTNT) EBT Growth (1y) (2011 - 2025)
Xtant Medical Holdings (XTNT) EBT Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 17.94% |
| 10 | Xtant Medical Holdings | 46.72 Mn | 29.11 Mn | 17.75 Mn | 150.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 150.83% |
| Sep 30, 2025 | 131.54% |
| Jun 30, 2025 | 199.48% |
| Mar 31, 2025 | 100.76% |
| Dec 31, 2024 | 15.62% |
| Sep 30, 2024 | -171.59% |
| Jun 30, 2024 | -75.70% |
| Mar 31, 2024 | -109.78% |
| Dec 31, 2023 | -70.29% |
| Sep 30, 2023 | 396.20% |
| Jun 30, 2023 | -28.29% |
| Mar 31, 2023 | 5.71% |
| Dec 31, 2022 | 7.95% |
| Sep 30, 2022 | -31.91% |
| Jun 30, 2022 | -145.94% |
| Mar 31, 2022 | -36,400.00% |
| Dec 31, 2021 | -397.28% |
| Sep 30, 2021 | -32.69% |
| Jun 30, 2021 | 71.73% |
| Mar 31, 2021 | 99.76% |